Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shalev

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.
Human Gene Therapy|November 1, 2001
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapyB J Miles, M Shalev, E Aguilar-Cordova, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2001
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary reportB S Teh, E Aguilar-Cordova, K Kernen, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.
Human Gene Therapy|November 1, 2001
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapyB J Miles, M Shalev, E Aguilar-Cordova, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2001
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary reportB S Teh, E Aguilar-Cordova, K Kernen, et al.
Pageof 8